导师风采
张玉石

个人信息

Personal Information

  • 性别:男
  • 导师类型:博导
  • 职称:主任医师
  • 该职称任职时间:9

联系方式

Contact Information

  • 所属院系:北京协和医院
  • 所属专业:
  • 邮箱 : zhangyushi@126.com
  • 工作电话 : 010-69152518

个人简介

Personal Profile

张玉石,北京协和医院泌尿外科主任医师,教授,博士研究生导师,泌尿外科主任。中华医学会泌尿外科学分会机器人学组委员,中国抗癫痫协会结节性硬化专业委员会委员,中国医师协会泌尿外科分会微创与机器人学组委员,中国医师协会泌尿外科分会肾上腺高血压协作组副组长,中国抗癌协会泌尿生殖肿瘤整合康复专业委员会常委,中国老年医学学会泌尿外科分会常委,中国医学救援协会急性疼痛医学分会副会长,北京慢性病防治与健康教育研究会老年泌尿系统疾病筛查与防治专业委员会副主任委员,北京医学会泌尿外科专业委员会委员,北京医师协会男科医师分会副会长,北京整合医学会泌尿外科学分会副会长。《中国临床案例成果数据库》学委会委员,《中华泌尿外科杂志》《现代泌尿外科杂志》《中华内分泌外科杂志》《中华诊断学电子杂志》《泌尿外科杂志(电子版)》《协和医学杂志》《临床军医杂志》《中国继续医学教育杂志》编委。

团队简介

Team Profile

目前研究团队10人,博士后6人,博士生4人。主要研究领域为肾上腺肿瘤的基础与临床,结节性硬化症相关肾血管平滑肌脂肪瘤的发病机理,肾癌的靶向与免疫治疗。

  • 研究方向Research Directions
肾上腺肿瘤的基础与临床研究
  • 在校研究生Current Graduate Students

硕士研究生 0 名,博士研究生 4 名

  • 科研项目Research Projects
# 项目名称 起止日期 金额 项目类型 本人角色
1miRNA-9对结节性硬化症生物行为的调控作用及机制研究2016-11-01 —— 2018-11-30主持的企业/行业委托重大项目主持人
2基于临床大数据的肾上腺外科疾病诊治标准化体系的建立2022-10-01 —— 2025-09-01主持的企业/行业委托重大项目主持人
3ATF2-miRNA9在结节性硬化症发生发展中的作用及机制研究2017-01-30 —— 2020-12-30主持在研的国家或省部级科研项目主持人
  • 发表论文Papers
# 论文题目 期刊名称 发表年份 论文署名
1CT characteristics predict the response to everolimus or sirolimus of renal angiomyolipomas in patients with tuberous sclerosis complex.International Urology and Nephrology2019-04-01通讯作者
2A pilot investigation of a urinary metabolic biomarker discovery in renal cell carcinomaINTERNATIONAL UROLOGY AND NEPHROLOGY2020-03-01通讯作者
3Investigation of Plasma Metabolic and Lipidomic Characteristics of a Chinese Cohort and a Pilot Study of Renal Cell Carcinoma BiomarkerFRONTIERS IN ONCOLOGY2020-08-01通讯作者
4LC-MS-Based Plasma Metabolomics and Lipidomics Analyses for Differential Diagnosis of Bladder Cancer and Renal Cell CarcinomaFRONTIERS IN ONCOLOGY2020-05-01通讯作者
5High Preoperative Plasma Fibrinogen Independently Predicts a Poor Prognosis in Patients with Nonmetastatic RCCJOURNAL OF CANCER2020-02-01通讯作者
6PTEN inhibitor VO-OHpic suppresses TSC2(-)(/)(-) MEFs proliferation by excessively inhibiting autophagy via the PTEN/PRAS40 pathwayEXPERIMENTAL AND THERAPEUTIC MEDICINE2020-06-01通讯作者
7UPLC-MS based urine untargeted metabolomic analyses to differentiate bladder cancer from renal cell carcinomaBMC CANCER2019-12-01通讯作者
8Urine Metabolomics for Renal Cell Carcinoma (RCC) Prediction: Tryptophan Metabolism as an Important Pathway in RCCFRONTIERS IN ONCOLOGY2019-07-01通讯作者
9The small size and superficial location suggest that laparoscopic partial nephrectomy is the first choice for the treatment of juxtaglomerular cell tumorsFRONT ENDOCRINOL (LAUSANNE)2021-04-30通讯作者
10High-throughput screening of circRNAs reveals novel mechanisms of tuberous sclerosis complex-related renal angiomyolipoma.Human Genomics2021-07-09通讯作者
11Integrative Analysis Identified MCT4 as an Independent Prognostic Factor for Bladder Cancer.Frontiers in Oncology2021-08-26通讯作者
12Analysis of serum lipid parameters predicting lipid metabolic disorders in TSC-AML patients with treatment of mTOR inhibitorsJOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS2022-03-01通讯作者
13Analysis of clinical features and next-generation sequencing of 12 tuberous sclerosis in China.FRONT MED2022-05-27通讯作者
14 Analysis of renal lesions in Chinese tuberous sclerosis complex patients with different types of TSC gene mutationsGENETICS AND MOLECULAR BIOLOGY2022-05-27通讯作者
15A Multi-Centric Study Assessing Safety and Efficacy of Everolimus in Adult Chinese Patients With Tuberous Sclerosis Complex Associated Renal AngiomyolipomasFrontiers in Oncology2022-07-04通讯作者
16Construction and validation of an m6A RNA methylation regulator prognostic model for early-stage clear cell renal cell carcinomaOncology Letters2022-08-01通讯作者
17A multi?omics study of diagnostic markers and the unique inflammatory tumor micro?environment involved in tuberous sclerosis complex?related renal angiomyolipomaINTERNATIONAL JOURNAL OF ONCOLOGY2022-11-01通讯作者
18Functional nodules in primary aldosteronism: identification of CXCR4 expression with 68Ga-pentixafor PET/CTEUROPEAN RADIOLOGY2022-09-07通讯作者
19UPLC-MS based integrated plasma proteomic and metabolomic profiling of TSC-RAML and its relationship with everolimus treatmentFrontiers in Molecular Biosciences2023-02-20通讯作者
20Construction of TSC2 knockout cell line using CRISPR/Cas9 system and demonstration of its effects on NIH-3T3 cellsCELL BIOCHEMISTRY AND BIOPHYSICS2022-10-01通讯作者
21Preclinical and pilot clinical evaluation of a small molecule carbonic anhydrase IX targeting PET tracer in clear cell renal cell carcinomaEUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING2023-05-12通讯作者
22Blood- and Urine-Based Liquid Biopsy for Early-Stage Cancer Investigation: Taken Clear Renal Cell Carcinoma as a ModelMOLECULAR & CELLULAR PROTEOMICS2023-06-20通讯作者
23Surgical strategies of complicated pheochromocytomas/ paragangliomas and literature reviewFrontiers in Endocrinology2023-04-21通讯作者
24Diagnostic efficacy of [ 68Ga]Ga‑NY104 PET/CT to identify clear cell renal cell carcinomaEUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING2024-06-25通讯作者
25Radiofrequency ablation plays double role in immunosuppression and activation of PBMCs in recurrent hepatocellular carcinomaFrontiers in Immunology2024-01-11通讯作者
26The predictive value of PFKFB3 in bladder cancer prognosisHeliyon2024-05-15通讯作者
27Juxtaglomerular cell tumor-case series of fourteen patients中国临床案例成果数据库2021-08-01通讯作者
28Solitary vaginal paraganglioma with mature sacrococcygeal teratoma:a rare case reportBMC endocrine disorders2021-07-07通讯作者
29Re: Masayuki Hagiwara, Atsushi Fushimi, Kazuhiro Matsumoto, Mototsugu Oya. The Significance of PARP1 as a Biomarker for Predicting the Response to PD-L1 Blockade in Patients with PBRM1-mutated Clear Cell Renal Cell Carcinoma. Eur Urol. 2022;81:145–8.EUR UROL2022-03-01通讯作者
30Re: Oscar Reig Torras, Akhilesh Mishra, Alana Christie, et al. Molecular Genetic Determinants of Shorter Time on Active Surveillance in a Prospective Phase 2 Clinical Trial in Metastatic Renal Cell Carcinoma. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.12.003.EUR UROL2022-05-03通讯作者
31The association between computed tomography attenuation value of renal angiomyolipoma associated with tuberous sclerosis complex and response to everolimusWORLD JOURNAL OF UROLOGY2024-01-06通讯作者
32Imaging CXCR4 Expression in Patients With Suspected Primary Hyperaldosteronism.EUR J NUCL MED MOL IMAGING2020-10-01第一作者
33Everolimus versus sirolimus for angiomyolipoma associated with tuberous sclerosis complex: a multi-institutional retrosepctive study in ChinaOrphanet J Rare Dis2021-07-01第一作者
  • 科研获奖Research Awards
# 获奖证书编号 奖项名称 获奖级别 获奖类别 获奖等级 获奖日期 颁奖单位 本单位是否为第一完成单位 完成单位排名 本人排序 备注
1201203007P0802肾上腺外科疾病基础与临床研究省部级华夏医学科技奖三等奖2012-12-30中国医学科学院 北京协和医学院 北京协和医院泌尿外科12
2201003031P0805肾上腺外科疾病诊治标准体系建立省部级中华医学科技奖三等奖2011-12-16中国医学科学院 北京协和医学院 北京协和医院泌尿外科15
  • 研究成果Research Findings
# 成果类型 项目/专利/新品种名称
1出版高水平专著原位新膀胱关键技术
2出版高水平专著内分泌外科学
3出版高水平专著肾上腺手术图谱
4出版高水平专著坎贝尔-沃尔什泌尿外科学(第2分册) 泌尿肿瘤与感染外科学
5出版高水平专著结节性硬化相关肾脏病变
6出版高水平专著遗传性肾癌-基础与临床
7出版高水平专著嗜铬细胞瘤/副神经节瘤外科诊疗策略
8出版高水平专著中华医学百科全书泌尿外科学
9出版高水平专著协和泌尿外科腹腔镜手术例释
10出版高水平专著协和肾上腺外科学
11出版高水平专著副神经节瘤/嗜铬细胞瘤病例3D影像解析
12出版高水平专著Surgical Management of Pheochromocytoma and Retro peritoneal Paraganglioma
13作为主创人员获得授权的发明专利和新品种一种包皮手术用的工具环